Alterations of several cancer suppressor genes (including TP53, LRP1B and CDKN2A) were related to higher GI/HRD scores, but alterations in oncogenes (including KRAS and ERBB2) were related to lower GI/HRD scores (Fig. 1b and Supplementary Fig. 1c). This evidence concerns the gene KRAS and cancer.